Literature DB >> 17404218

Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals.

David M Mills1, Giuseppina Bonizzi, Michael Karin, Robert C Rickert.   

Abstract

NF-kappaB-inducing kinase (NIK)-mediated IKKalpha phosphorylation activates the alternative NF-kappaB pathway, which is characterized by nuclear translocation of p52:RelB heterodimers. This alternative pathway is initiated by a select few receptors, including LT-betaR, BAFF-R, and CD40. Although NIK, IKKalpha, and p52 are all critical regulators of LT-betaR signaling in stromal cells during humoral immune responses, lymphocytes require NIK, but not p52, for optimal Ig production. This disparity suggests that NIK possesses critical cell-type-specific functions that do not depend on NF-kappaB. Here we use mice bearing targeted mutations of the IKKalpha activation loop Ser(176/180) (IKKalpha(AA)) to address the B cell-intrinsic functions of NIK-IKKalpha signaling in vivo. We find that IKKalpha(AA) B cells mount normal primary antibody responses but do not enter germinal centers. This defect likely derives from ineffective early T-B cell collaboration and leads to impaired generation of humoral memory and relatively short-lived, low-affinity antibody production. Our findings contrast with those obtained by using p52(-/-) B cells, which mount normal Ig responses, and alymphoplasia (NIK mutant) B cells, which produce very little primary Ig. Thus, the NIK-IKKalpha-p52 axis is not as linear and exclusive as previous studies suggest, and IKKalpha possesses critical NF-kappaB-independent functions in B cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404218      PMCID: PMC1851084          DOI: 10.1073/pnas.0700296104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase.

Authors:  T Yamada; T Mitani; K Yorita; D Uchida; A Matsushima; K Iwamasa; S Fujita; M Matsumoto
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines.

Authors:  D S Weih; Z B Yilmaz; F Weih
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

Review 3.  Follicular stromal cells and lymphocyte homing to follicles.

Authors:  J G Cyster; K M Ansel; K Reif; E H Ekland; P L Hyman; H L Tang; S A Luther; V N Ngo
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

4.  Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect.

Authors:  U Karrer; A Althage; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

5.  IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression.

Authors:  Zheng Tu; Shashi Prajapati; Kyu-Jin Park; Nathan J Kelly; Yumi Yamamoto; Richard B Gaynor
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

6.  NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.

Authors:  Carmen Sánchez-Valdepeñas; Angel G Martín; Parameswaran Ramakrishnan; David Wallach; Manuel Fresno
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

7.  IkappaB kinase alpha is essential for mature B cell development and function.

Authors:  T Kaisho; K Takeda; T Tsujimura; T Kawai; F Nomura; N Terada; S Akira
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

8.  Lineage-restricted function of nuclear factor kappaB-inducing kinase (NIK) in transducing signals via CD40.

Authors:  N Garceau; Y Kosaka; S Masters; J Hambor; R Shinkura; T Honjo; R J Noelle
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system.

Authors:  S Fagarasan; R Shinkura; T Kamata; F Nogaki; K Ikuta; K Tashiro; T Honjo
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.

Authors:  A Matsushima; T Kaisho; P D Rennert; H Nakano; K Kurosawa; D Uchida; K Takeda; S Akira; M Matsumoto
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  29 in total

Review 1.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 3.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

4.  NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.

Authors:  Hans Häcker; Liying Chi; Jerold E Rehg; Vanessa Redecke
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

Review 5.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

6.  A novel role of IKKalpha in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression.

Authors:  Lun Song; Wen Dong; Ming Gao; Jingxia Li; Meiru Hu; Ning Guo; Chuanshu Huang
Journal:  Biochim Biophys Acta       Date:  2010-01-15

7.  Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.

Authors:  Yulia N Demchenko; Oleg K Glebov; Adriana Zingone; Jonathan J Keats; P Leif Bergsagel; W Michael Kuehl
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

8.  Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in males.

Authors:  Jean-Brice Marteau; Odile Rigaud; Thibaut Brugat; Nathalie Gault; Laurent Vallat; Mogens Kruhoffer; Torben F Orntoft; Florence Nguyen-Khac; Sylvie Chevillard; Hélène Merle-Beral; Jozo Delic
Journal:  BMC Med Genomics       Date:  2010-11-10       Impact factor: 3.063

9.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

10.  RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke.

Authors:  Se-Ran Yang; Hongwei Yao; Saravanan Rajendrasozhan; Sangwoon Chung; Indika Edirisinghe; Samantha Valvo; George Fromm; Michael J McCabe; Patricia J Sime; Richard P Phipps; Jian-Dong Li; Michael Bulger; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.